Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/1998
03/10/1998US5726175 Imidazo 1,2-A!indeno 1,2-E!pyrazine-2-carboxylic acid derivatives, preparation thereof and drugs containing same
03/10/1998US5726169 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
03/10/1998US5726166 Inositol monophosphate or a phosphatidyl inositol
03/10/1998US5726158 Peptide derivatives
03/10/1998US5726156 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
03/10/1998US5726149 Treatment of glomerulonephritis with decorin
03/10/1998US5726148 Method of treating metabolic bone diseases with an IL-1 receptor
03/10/1998US5726037 Host cells and method of producing soluble analogues of integrins
03/10/1998US5726036 Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
03/10/1998US5726035 Recombinant production of mammalian calcium channel gamma subunits
03/10/1998US5726023 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
03/10/1998US5725878 Pharmaceutical composition comprising HIV protease inhibiting compounds
03/10/1998US5725851 Method and compositions for treating injury
03/10/1998CA1339707C Formulations for recombinant beta-interferon
03/09/1998CA2214728A1 Substituted amino acid derivatives
03/06/1998CA2209890A1 Apoptotic agents for tumor cells of the nervous system
03/05/1998WO1998008955A1 Stimulus-inducible i (kappa)b kinase [ikk] signalsome
03/05/1998WO1998008941A1 Thiomethylene group-containing aldehyde cysteine and serine protease inhibitors
03/05/1998WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
03/05/1998WO1998008863A1 Enzyme and dna sequence encoding same
03/05/1998WO1998008855A2 N6 heterocyclic substituted adenosine derivatives
03/05/1998WO1998008853A1 Phosphinic acid amides as matrix metalloprotease inhibitors
03/05/1998WO1998008850A1 Spirocyclic metalloprotease inhibitors
03/05/1998WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives
03/05/1998WO1998008846A1 Substituted 6,6-hetero-bicyclic derivatives
03/05/1998WO1998008840A1 Integrin antagonists
03/05/1998WO1998008835A1 Spirocyclic dopamine receptor subtype ligands
03/05/1998WO1998008827A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008826A1 Piperazino derivatives as neurokinin antagonists
03/05/1998WO1998008825A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998WO1998008823A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008822A1 1,3-diheterocyclic metalloprotease inhibitors
03/05/1998WO1998008819A1 4-aminoethoxy indolone derivatives
03/05/1998WO1998008818A1 Inhibitors of phospholipase enzymes
03/05/1998WO1998008817A1 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht1a ligands
03/05/1998WO1998008815A1 Substituted cyclic amine metalloprotease inhibitors
03/05/1998WO1998008814A1 Bidentate metalloprotease inhibitors
03/05/1998WO1998008548A2 Stable radioiodine conjugates and methods for their synthesis
03/05/1998WO1998008546A2 Therapeutic combinations of rar antagonists and rxr agonists and use thereof
03/05/1998WO1998008538A1 Use of hyaluronidase
03/05/1998WO1998008537A1 Enhanced stimulation of erythropoiesis
03/05/1998WO1998008532A1 Methods of treating renal disease with a gastrin releasing peptide receptor antagonist
03/05/1998WO1998008529A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008528A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008513A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/05/1998WO1998008509A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of aids
03/05/1998WO1998008508A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of htlv-1 infections
03/05/1998WO1998008505A1 Pharmaceutical compounds
03/05/1998WO1998008502A1 SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b]BENZOFURANS
03/05/1998WO1998008498A1 Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants
03/05/1998WO1998008494A1 Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
03/05/1998WO1998008480A2 Method of using tetracycline compounds for inhibition of nitric oxide production
03/05/1998WO1998008382A1 Nonclassical pyrrolo[2,3-d]pyrimidine antifolates
03/05/1998WO1998002452A3 Compounds and methods for modulating cell adhesion
03/05/1998WO1998001552A3 Secreted proteins and polynucleotides encoding them
03/05/1998WO1997047296A3 Compositions comprising vanadium compounds for use in the treatment of proliferative disorders and arthropathies
03/05/1998WO1997046226A3 USE OF INHIBITORS OF THE CELLULAR Na+/H+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS
03/05/1998WO1997037688A3 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
03/05/1998CA2670296A1 Method of using tetracycline compounds for inhibition of nitric oxide production
03/05/1998CA2264715A1 Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
03/05/1998CA2264577A1 Treatment of spasticity, convulsions by isovaleric acid derivatives cns depressants
03/05/1998CA2264309A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998CA2264267A1 Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta¬b|benzofurans
03/05/1998CA2264266A1 1,3-diheterocyclic metalloprotease inhibitors
03/05/1998CA2264080A1 4-aminoethoxy indoles as dopamin d2 agonists and as 5ht1a ligands
03/05/1998CA2264078A1 4-aminoethoxy indolone derivatives
03/05/1998CA2264045A1 Heterocyclic metalloprotease inhibitors
03/05/1998CA2264044A1 Spirocyclic metalloprotease inhibitors
03/05/1998CA2264020A1 Inhibitors of phospholipase enzymes
03/05/1998CA2263999A1 Integrin antagonists
03/05/1998CA2263985A1 Stable radioiodine conjugates and methods for their synthesis
03/05/1998CA2263978A1 Enhanced stimulation of erythropoiesis
03/05/1998CA2263932A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998CA2263928A1 Substituted cyclic amine metalloprotease inhibitors
03/05/1998CA2263917A1 Heterocyclic metalloprotease inhibitors
03/05/1998CA2263914A1 Bidentate metalloprotease inhibitors
03/05/1998CA2263907A1 Nonclassical pyrrolo[2,3-d]pyrimidine antifolates
03/05/1998CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use
03/05/1998CA2263817A1 Therapeutic combinations of rar antagonists and rxr agonists and use thereof
03/05/1998CA2263499A1 Use of inhibitors of pkc for the manufacture of a medicament for the treatment of central nervous system diseases associated with hiv infection
03/05/1998CA2263175A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/05/1998CA2263161A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of htlv-1 infections
03/05/1998CA2263133A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of aids
03/05/1998CA2259151A1 Enzyme and dna sequence encoding same
03/04/1998EP0826772A2 Human mucin (MUC8)
03/04/1998EP0826685A1 Stable, long acting salts of carboxamides for the treatment of joint disease
03/04/1998EP0826682A1 Amorphous benzothiophenes, methods of preparation, and methods of use
03/04/1998EP0826676A1 Oxazole derivatives and use thereof
03/04/1998EP0826657A1 Compounds for modulation of hormone receptors, compositions containing them and their use in therapy
03/04/1998EP0826374A2 Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases
03/04/1998EP0826368A1 Use of retinoids for the preparation of a medicament for treating disorders related to VEGF overexpression
03/04/1998EP0826367A2 Use of an extract of Bertholletia in cosmetics or in pharmaceuticals, and for the preparation of cell-culture media
03/04/1998EP0826056A2 Stable variant hk2 polypeptide
03/04/1998EP0826044A1 Bmp-15 compositions
03/04/1998EP0826043A1 Methods for modulating t cell survival by modulating bcl-x l? protein level
03/04/1998EP0826041A1 Transforming growth factor alpha hii
03/04/1998EP0826002A2 Biologically active peptide fragments of ob protein
03/04/1998EP0826000A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
03/04/1998EP0825993A1 Xanthines and their therapeutic use
03/04/1998EP0825991A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
1 ... 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 ... 1564